RE: I'm in!!!1 Oct 2019 12:38
Dr Tom Oakley, CEO of Feedback, commented:
"We are demonstrating Bleepa for the first time at Expo with leaders who are driving digital innovation across the NHS. The role of digital technology in revolutionising patient care is central to the NHS Long Term Plan and we believe Bleepa sits firmly at the heart of this movement, enabling clinicians to share high quality medical images and discuss how to give the best possible patient care securely and quickly via mobile devices."
Bleepa is an innovative new app based on Feedback's Cadran technology, which allows medical staff to securely view and discuss high quality medical grade images on mobile devices. The app will display images directly from the hospital's Picture Archive Communication System (PACS). Bleepa can display any type of image including X-rays, CTs, MRIs and ultrasound studies allowing users to easily scroll through image slices and annotate areas of interest. Questions can be asked alongside annotations and submitted into the chat where they can be securely reviewed by colleagues at the swipe of a finger, with instant access to the original image.
Bleepa enables faster clinical decisions as doctors will be able to share, review and discuss images including screen sharing with multiple staff, both accelerating and improving patient care. All data and resulting decisions will be stored in hospital records for later review.
Currently, it is only possible to view medical grade images on desktop computers and discuss them by telephone. According to BMJ Innovations, 97% of hospital doctors routinely use WhatsApp to communicate about patients. This increasing trend for clinicians to use personal devices to discuss patient care and make clinical decisions is more convenient and efficient than traditional methods of clinical communication. However, these images are not of sufficient quality to make clinical decisions and sharing data in this way breaches data protection legislation, leaving hospitals and individual staff open to the risk of litigation.
The Directors believe Bleepa will be the leading communication tool on the market and will be a CE marked medical device.